Dallah Healthcare Company (4004.SR)
SAR 157.6
(0.38%)
SAR 157.6
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 625.78 Million | 442.13 Million | 361.54 Million | 183.3 Million | 307.12 Million | 204.68 Million |
| Net Income | 400.31 Million | 329.13 Million | 291.83 Million | 113.54 Million | 151.62 Million | 145.29 Million |
| Depreciation & Amortization | 125.61 Million | 114.26 Million | 115.11 Million | 95.08 Million | 92.66 Million | 74.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -42.97 Million | -117.46 Million | -128.42 Million | -75.44 Million | 36.36 Million | -37.85 Million |
| Other non-cash items | 142.83 Million | 116.2 Million | 83.02 Million | 50.11 Million | 26.46 Million | 22.72 Million |
| Investing Cash Flow | -293.68 Million | -225.93 Million | -425.29 Million | -427.53 Million | -220.91 Million | -234.28 Million |
| Investments in PPE | -296.65 Million | -174.99 Million | -115.68 Million | -129.65 Million | -201.06 Million | -256.08 Million |
| Acquisitions | 1.26 Million | -56.26 Million | -21.84 Million | -276.68 Million | 28.76 Thousand | -5.98 Million |
| Investment purchases | - | -282.82 Thousand | -291.95 Million | -23.33 Million | -22.32 Million | -5.98 Million |
| Sales/Maturities of investments | - | - | 70 Thousand | 280 Thousand | 2.43 Million | 27.75 Million |
| Other Investing Activities | 1.71 Million | 5.6 Million | 4.12 Million | 1.85 Million | -19.85 Million | 24.71 Thousand |
| Financing Cash Flow | -334.73 Million | -186.33 Million | 141.18 Million | 286.55 Million | -44.24 Million | -14.47 Million |
| Debt repayment | -273.87 Million | -656.68 Million | -378.16 Million | -427.91 Million | -583.98 Million | -2.31 Billion |
| Dividends payments | -146.52 Million | -180 Million | -162.5 Million | -99.88 Million | -123.87 Million | -147.5 Million |
| Common Stock Repurchased | - | - | - | - | -190.45 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 93.41 Million | 650.35 Million | 681.84 Million | 814.34 Million | 854.06 Million | 2.44 Billion |
| Accounts receivables | -76.35 Million | -57.92 Million | -96.77 Million | -156.06 Million | 12.34 Million | -44.53 Million |
| Accounts payables | 6.81 Million | 25.93 Million | 29.24 Million | 35.88 Million | 32.93 Million | 11.67 Million |
| Inventory | 30.46 Million | -38.69 Million | -52.21 Million | -18.96 Million | -15.7 Million | -11.47 Million |
| Other working capital | -3.9 Million | -46.78 Million | -8.68 Million | 63.69 Million | 6.78 Million | -26.37 Million |
| Cash at beginning of period | 237.94 Million | 208.07 Million | 130.64 Million | 88.32 Million | 46.35 Million | 90.44 Million |
| Cash at end of period | 235.3 Million | 237.94 Million | 208.07 Million | 130.64 Million | 88.32 Million | 46.35 Million |
| Capital Expenditure | -296.65 Million | -174.99 Million | -115.68 Million | -129.65 Million | -201.06 Million | -256.08 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.63 Million | 29.86 Million | 77.43 Million | 42.31 Million | 41.96 Million | -44.08 Million |
| Free Cash Flow | 329.12 Million | 267.13 Million | 245.85 Million | 53.64 Million | 106.06 Million | -51.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 111.84 Million | 130.53 Million | 400.31 Million | 114.66 Million | 111.25 Million | 66.82 Million |
| Depreciation & Amortization | 34.47 Million | 35.7 Million | 125.61 Million | 32.56 Million | 32.64 Million | 29.72 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -86.35 Million | -18.74 Million | -42.97 Million | 87.31 Million | -39.37 Million | 16.57 Million |
| Other non-cash items | 177.15 Million | 28.95 Million | 142.83 Million | 35.34 Million | 28.82 Million | 33.79 Million |
| Investing Cash Flow | -64.51 Million | -53.18 Million | -293.68 Million | -135.43 Million | -72.33 Million | -30.79 Million |
| Investments in PPE | -64.51 Million | -53.18 Million | -296.65 Million | -151.31 Million | -72.33 Million | -32.02 Million |
| Acquisitions | - | - | 1.26 Million | 13.75 Million | -13.75 Million | 13.75 Million |
| Investment purchases | - | - | - | 13.75 Million | 13.75 Million | -12.52 Million |
| Sales/Maturities of investments | - | - | - | -13.75 Million | 941.03 Thousand | 1488.00 |
| Other Investing Activities | 7.02 Million | - | 1.71 Million | 2.12 Million | -941.03 Thousand | -1488.00 |
| Financing Cash Flow | -81.05 Million | -141.95 Million | -334.73 Million | -42.37 Million | -156.04 Million | -56.26 Million |
| Debt repayment | -57.17 Million | -54.87 Million | -273.87 Million | -51.95 Million | -75.3 Million | -70.84 Million |
| Dividends payments | - | -48.84 Million | -146.52 Million | -41.08 Million | -97.68 Million | - |
| Common Stock Repurchased | -14.98 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -20.99 Thousand | -281.26 Thousand | 93.41 Million | 58.42 Million | 16.93 Million | 14.58 Million |
| Accounts receivables | -103.15 Million | 10.87 Million | -76.35 Million | 92.44 Million | -70.18 Million | 5.84 Million |
| Accounts payables | 43.14 Million | 8.67 Million | 6.81 Million | 12.19 Million | -10.29 Million | 18.88 Million |
| Inventory | -33.19 Million | -915.37 Thousand | 30.46 Million | -10.41 Million | 20.06 Million | 13.67 Million |
| Other working capital | 6.85 Million | -41.75 Million | -3.9 Million | -6.9 Million | 21.04 Million | -21.82 Million |
| Cash at beginning of period | 213.63 Million | 235.3 Million | 237.94 Million | 143.22 Million | 238.25 Million | 178.39 Million |
| Cash at end of period | 143.02 Million | 213.63 Million | 235.3 Million | 235.3 Million | 143.22 Million | 238.25 Million |
| Capital Expenditure | -64.51 Million | -53.18 Million | -296.65 Million | -151.31 Million | -72.33 Million | -32.02 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -70.6 Million | -21.66 Million | -2.63 Million | 92.08 Million | -95.03 Million | 59.86 Million |
| Free Cash Flow | 10.44 Million | 120.28 Million | 329.12 Million | 118.58 Million | 61.01 Million | 114.9 Million |
FOUR
0KAV
NCC-B
4875
6485
FROG